Nasdaq

Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV

ABBOTT PARK, Ill., Nov. 2, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, ...
Crain's Chicago Business

Abbott adds HPV primary screening to Alinity test family

Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
Nasdaq

Abbott’s Alinity m Resp-4-Plex Test Cleared For Emergency Use In US; Street Says Buy

Abbott’s Alinity m Resp-4-Plex molecular assay, which was designed to test for four viruses in one test, has been authorized for emergency use by the US Food and Drug Administration (FDA). Shares of ...
Seeking Alpha

Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV

According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...